Showing results (201-210 of 256) with videos related to
Sort By:
Pageof 26
Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes|August 20, 2011
Osteoporosis Canada 2010 guidelines for the assessment of fracture riskBrian Lentle, Angela M Cheung, David A Hanley, et al.The Journal of Nutrition|July 30, 2010
Supplemental barley protein and casein similarly affect serum lipids in hypercholesterolemic women and menDavid J A Jenkins, Korbua Srichaikul, Julia M W Wong, et al.Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|November 16, 2005
Are oral bisphosphonates effective in improving lumbar bone mineral density in breast cancer survivors with osteopenia or osteoporosis?Anna M Sawka, George Ioannidis, Alexandra Papaioannou, et al.Diabetes Care|August 28, 2002
Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetesDavid J A Jenkins, Cyril W C Kendall, Livia S A Augustin, et al.European Journal of Clinical Nutrition|May 19, 2005
Direct comparison of dietary portfolio vs statin on C-reactive proteinD J A Jenkins, C W C Kendall, A Marchie, et al.Metabolism: Clinical and Experimental|December 15, 2007
Effect of plant sterols in combination with other cholesterol-lowering foodsDavid J A Jenkins, Cyril W C Kendall, Tri H Nguyen, et al.Diabetologia|January 9, 2019
Correction to: Nuts as a replacement for carbohydrates in the diabetic diet: a reanalysis of a randomised controlled trialDavid J A Jenkins, Cyril W C Kendall, Benoît Lamarche, et al.Nutrients|December 4, 2015
Effect of Replacing Animal Protein with Plant Protein on Glycemic Control in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsEffie Viguiliouk, Sarah E Stewart, Viranda H Jayalath, et al.JAMA|July 24, 2003
Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive proteinDavid J A Jenkins, Cyril W C Kendall, Augustine Marchie, et al.Circulation|June 20, 2017
Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin)Neha J Pagidipati, Ann Marie Navar, Karen S Pieper, et al.Pageof 26